» Articles » PMID: 33953324

The Evolution and Future of Influenza Pandemic Preparedness

Overview
Journal Exp Mol Med
Date 2021 May 6
PMID 33953324
Citations 72
Authors
Affiliations
Soon will be listed here.
Abstract

The influenza virus is a global threat to human health causing unpredictable yet recurring pandemics, the last four emerging over the course of a hundred years. As our knowledge of influenza virus evolution, distribution, and transmission has increased, paths to pandemic preparedness have become apparent. In the 1950s, the World Health Organization (WHO) established a global influenza surveillance network that is now composed of institutions in 122 member states. This and other surveillance networks monitor circulating influenza strains in humans and animal reservoirs and are primed to detect influenza strains with pandemic potential. Both the United States Centers for Disease Control and Prevention and the WHO have also developed pandemic risk assessment tools that evaluate specific aspects of emerging influenza strains to develop a systematic process of determining research and funding priorities according to the risk of emergence and potential impact. Here, we review the history of influenza pandemic preparedness and the current state of preparedness, and we propose additional measures for improvement. We also comment on the intersection between the influenza pandemic preparedness network and the current SARS-CoV-2 crisis. We must continually evaluate and revise our risk assessment and pandemic preparedness plans and incorporate new information gathered from research and global crises.

Citing Articles

Human mobility and the infectious disease transmission: A systematic review.

Lessani M, Li Z, Jing F, Qiao S, Zhang J, Olatosi B Geo Spat Inf Sci. 2025; 27(6):1824-1851.

PMID: 40046953 PMC: 11882145. DOI: 10.1080/10095020.2023.2275619.


Antiviral activity of silver nanoparticles against H1N1 influenza virus.

Seyfi M, Letafati A, Edalat F, Shatizadeh Malekshahi S, Pirbonyeh N, Moattari A BMC Res Notes. 2025; 18(1):75.

PMID: 39966976 PMC: 11834247. DOI: 10.1186/s13104-025-07143-0.


An mRNA vaccine candidate encoding cholera toxin subunit B and conserved antigens of influenza viruses confers cross-protection against influenza a viruses in adult and aged mice.

Xu L, Yu Z, Xu Y, Wang Q, Wang G, Li B Hum Vaccin Immunother. 2025; 21(1):2453304.

PMID: 39957235 PMC: 11834421. DOI: 10.1080/21645515.2025.2453304.


Seasonal influenza surveillance and vaccination policies in the WHO South-East Asian Region.

Haider S, Hassan M BMJ Glob Health. 2025; 10(2).

PMID: 39939109 PMC: 11822389. DOI: 10.1136/bmjgh-2024-017271.


Understanding Influenza.

Hutchinson E, Amorim M, Yamauchi Y Methods Mol Biol. 2025; 2890:1-26.

PMID: 39890719 DOI: 10.1007/978-1-0716-4326-6_1.


References
1.
Kash J, Taubenberger J . The role of viral, host, and secondary bacterial factors in influenza pathogenesis. Am J Pathol. 2015; 185(6):1528-36. PMC: 4450310. DOI: 10.1016/j.ajpath.2014.08.030. View

2.
Lehnert R, Pletz M, Reuss A, Schaberg T . Antiviral Medications in Seasonal and Pandemic Influenza. Dtsch Arztebl Int. 2017; 113(47):799-807. PMC: 5240024. DOI: 10.3238/arztebl.2016.0799. View

3.
Smith G, Vijaykrishna D, Bahl J, Lycett S, Worobey M, Pybus O . Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature. 2009; 459(7250):1122-5. DOI: 10.1038/nature08182. View

4.
Erbelding E, Post D, Stemmy E, Roberts P, Augustine A, Ferguson S . A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases. J Infect Dis. 2018; 218(3):347-354. PMC: 6279170. DOI: 10.1093/infdis/jiy103. View

5.
Gao R, Cao B, Hu Y, Feng Z, Wang D, Hu W . Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med. 2013; 368(20):1888-97. DOI: 10.1056/NEJMoa1304459. View